{"name":"Han Wha Pharma Co., Ltd.","slug":"han-wha-pharma-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTFBuSEszYXduUmtKR2x2MGlXUDJyeG8wOXY0NjNILXozSWx1TDlxUUZFblgxelo1Z2NpNTRFZmxuaXZXRldwWE1yVUFobkF2Z2diUVRfWlVxekd4MnV1V1ZIcXBGUk9fdw?oc=5","date":"2026-04-03","type":"pipeline","source":"thelec.net","summary":"Hanwha Solutions Says No Additional Equity Issuance Planned Through 2030 - thelec.net","headline":"Hanwha Solutions Says No Additional Equity Issuance Planned Through 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE5QMUVKOVRVeERBTnMwaTZtNFRIWGRvSDZ0b0Z1b29rd1o1b1BLV01zdGJ5MzlCVmx3RFE5elo5NmJGdjFtWF9VTXdtYjNVRnFOMjJWOTVaWl9XOXRrcVVKVEpNVnlJLVk4YWcxT0d6Q1A?oc=5","date":"2026-04-01","type":"pipeline","source":"Fathom Journal","summary":"LPGA Now | Hanwha LIFEPLUS International Crown Day 4 [a707f5] - Fathom Journal","headline":"LPGA Now | Hanwha LIFEPLUS International Crown Day 4 [a707f5]","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPa2RrZDJKcllvM3BuMS1MS1N1T2pNTDdZRXkwYjZPZk1MSVc2SGhLaUpwbXJGTWFZSTVqUnJ1UFExRUVtdm1iNERzeTF5RHgwdzB4elZ4dFA1dDk3SGtpWFlZcTBCTTZzcXZyWThnMnRHSGswNnY3VlRad2pJNEZXa1RnNnNXWGZuREM4M3dJMTNEUHRsU0U5N0p1WlhIWVYzbFFB?oc=5","date":"2026-03-16","type":"deal","source":"BioWorld News","summary":"G2Gbio secures license deal, ₩20B investment from Samsung Epis - BioWorld News","headline":"G2Gbio secures license deal, ₩20B investment from Samsung Epis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNNC1lbGZmZUw1QXpCOUotam52cDloS3RwbnhUWnBlN2JrTUVUMUw5enJEZjVLYmNaeEdid2tYQUgtSEZNSWZpc0Y4QVViSnY4WmNWZ0lKRC1kUzZiRUdGSXJyc3BWTEo1UzRyZERSOXF5YmVNOW81aWZHc1ZxaGd0Sw?oc=5","date":"2026-01-04","type":"patent","source":"Insightace Analytic","summary":"Psoriasis Biosimilars Market Size, Share and New Trends 2026 to 2035 - Insightace Analytic","headline":"Psoriasis Biosimilars Market Size, Share and New Trends 2026 to 2035","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPbnY1NHpvdmJLcFlfOVpmYXJZbXQ4S2FvR1pqdnhxREI0M0dPNExub3FIR1draTJCeDZBc1EyOWtyQmh4R3pfZHBSem56Zmc4R2l1Xzg1YzlxT2FTU2gyNlRQZG9STTQxcnozbFB3WC1yZkRTSFN5WG04d1VCdWZpcXpSSXdSRmd3TnREVGhiWUhYRDJTd3JCYnV3SldjemRaOEd1YlFwRjRfSTdSX3JucGFTbnpteVpCcFktQQ?oc=5","date":"2025-11-14","type":"deal","source":"Reuters","summary":"US, South Korea release details of trade deal - Reuters","headline":"US, South Korea release details of trade deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNLXVabC16em9CaVpEMXNDc2t2U25JQ0tLTjhLak95TXdOTUM2M09UUUs1YXpBcFJGaWZ6UjhHSjFEclU2NFZGWXNKYzJZREM2N1pSX2Nmcmc3TER2TXFBbzlIYkFSQlF2dVdSOUk5WjBheUh3LWR5eHVuQWJKWlZnTi1LempSaGdfOHNNQkVkT00tR01KUVkzZWpSOVpVU1Y2QTVFckpGUmxPdm85Mnc?oc=5","date":"2025-10-31","type":"pipeline","source":"iPolitics","summary":"Lobby Wrap: GlaxoSmithKline wants to talk about vaccines and other issues - iPolitics","headline":"Lobby Wrap: GlaxoSmithKline wants to talk about vaccines and other issues","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOeEp5N3NyWWR6NnNieWJ2Y1NpRjRIeGlyZVVjSmVqNXRxNVpVQnFIclhFZEpFRURncmVyUDltRFlnWFJzME9fYThfQjNKRWd2ZVNIWExOOWEtTWVTOVdSVExHY2hNdG02dXVrMmFLRVhWVjNyU3dCMEhzcEV2MzREeUpOYjJ5dlJJYnl2akg1TWo5VGtPRW1xTVo1aw?oc=5","date":"2025-08-19","type":"pipeline","source":"BioWorld News","summary":"Microsphere injectables biotech G2Gbio debuts with $38M - BioWorld News","headline":"Microsphere injectables biotech G2Gbio debuts with $38M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFBlYXNadmJEZGM1OVp4MWhTakRhTC1SaGp3ZTNYTHREUzVSUldmbHNjYTBqMTJ4RHlXTVE5NXpjVjFtdy1CbjRRVzlmYUZqQ2dKWGNNNFlZaE1Od2lSX28tRGFCRmNmdzBEUFNTalloQ1UxeGZSa1Zz?oc=5","date":"2025-08-01","type":"pipeline","source":"KED Global","summary":"Winners & losers: S.Korean industries navigate uneven US tariff terrain - KED Global","headline":"Winners & losers: S.Korean industries navigate uneven US tariff terrain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQYjNrb1ZmNkxHdmlkS1RNZjJ6Q0VtT1d1d1ZMUXN6alNnOUVjM0s1bHFWWURZSFJHckxjWXJ0eU85UG9YVHBXTVBFUkFCQjFHSUFTam5VRWxwLVp2WFlJRzFmdTFnSFZJU0NTbk5idmttXy1faVJRU3lVOUNqWGVXWTJ3?oc=5","date":"2025-06-25","type":"patent","source":"Insightace Analytic","summary":"TNF Biosimilars Market is expected to grow at a 16.5% CAGR during the forecast period for 2025-2034. - Insightace Analytic","headline":"TNF Biosimilars Market is expected to grow at a 16.5% CAGR during the forecast period for 2025-2034.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE1WNWVRYUlVSWMtVUY3RVVOdlVyemJKdUZ5ZjBiQW1QN0ljbEJRXzZ3czJIY3VfSmhQMWRpNmJUMThteVZPRTN5eldvNWZrT3ZZOXpENjNBanU4T0FNYmFfVjdiNXhhOUs3Z3RtemplX2otTWpwQzVheQ?oc=5","date":"2025-06-02","type":"pipeline","source":"Naval Technology","summary":"Hanwha Ocean signs MOUs with BlackBerry, L3 Harris MAPPS - Naval Technology","headline":"Hanwha Ocean signs MOUs with BlackBerry, L3 Harris MAPPS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE8xRVBCRlpSS1hGQ0pSYU5RbjcyekVaOUJ3NVlTYXNYckwtMmZwMG5xYkI4V3RRa3hwSi0zVnhucEV5THhXb3YzUzVDbUVDdEdENUZOZXp5S0ZBOWtiVkhaT29qMDAyM0VONHUyNGdn0gFyQVVfeXFMTWxHeU5yd2JwbFV1b2xBdDczT3FJaDk1QUlZaU9naGdkT1paOEpaSFRPbHpCV1dXVl9FU29rQjJOckZVM0pKamJsckR2aUNDSUpxeGdoQ3hxbWtaV1AzQXlDeC1jSzNZT04tLXV3OGdueFV3?oc=5","date":"2024-01-19","type":"deal","source":"koreabiomed.com","summary":"Dongwha Pharm acquires 4 of Celltrion's over-the-counter products - koreabiomed.com","headline":"Dongwha Pharm acquires 4 of Celltrion's over-the-counter products","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1uQ3hGSWpId0hMcGZWUjFrZ3pBeGdHLTVIakpMQWVPZ3N3M1lkTHlveHpVdzdzOXZYc1FxdkV5ejRDaVpRWjBPYU5wdnFMbW1uQUtBT3ZDXzJVWk9OcUZwbFVkWk9td1k4ZU9mUHBB?oc=5","date":"2023-12-05","type":"pipeline","source":"KED Global","summary":"Hanwha to re-enter biopharma market, targeting biomaterials - KED Global","headline":"Hanwha to re-enter biopharma market, targeting biomaterials","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}